SOLESENCE, INC. — Director's Dealing 2019

May 30, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES Corp (NANX)
CIK: 0000883107
Period of Report: 2019-05-22

Reporting Person: JANKOWSKI JESS (Director, President, CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-22	Common Stock (right to purchase)	$0.51	A	16500	Acquired	2029-05-22	Common Stock (16500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1000	Indirect
Common Stock	59000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock (right to purchase)	$1.02	2019-05-04	Common Stock (30000)	30000	Direct
Common Stock (right to purchase)	$1.70	2020-05-03	Common Stock (27000)	27000	Direct
Common Stock (right to purchase)	$1.26	2021-05-02	Common Stock (85000)	85000	Direct
Common Stock (right to purchase)	$0.30	2022-08-07	Common Stock (98000)	98000	Direct
Common Stock (right to purchase)	$0.415	2023-02-14	Common Stock (90000)	90000	Direct
Common Stock (right to purchase)	$0.52	2024-02-13	Common Stock (90000)	90000	Direct
Common Stock (right to purchase)	$0.44	2025-02-18	Common Stock (81000)	81000	Direct
Common Stock (right to purchase)	$0.42	2026-02-23	Common Stock (69000)	69000	Direct
Common Stock (right to purchase)	$0.68	2027-02-21	Common Stock (81000)	81000	Direct
Common Stock (right to purchase)	$0.82	2028-05-23	Common Stock (90000)	90000	Direct

Footnotes

F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

F2: Subject to certain restrictions, beginning on this date, options vest in three equal installments.

F3: Subject to certain restrictions, beginning on this date, the options vest in three equal annual installments.